Public healthcare should also work with priorities. What has more priority? Financial or geographical accessibility? Quality or quantity? What should be clearly free and, conversely, what is the Slovak patient-insured-consumer willing to pay for?
The pandemic period has not been kind to some patients’ relationship with health professionals. A period of information uncertainty, spawning hoaxes. The patient with their own opinion and their own information falls under a crooked gaze.
There are private solutions, for healthcare, schools, and transport. They are popular or at least coveted. Yet, there is a catch. The state always lurks beneath the surface. Many taxi companies are owned by cronies and have a huge lobbying power. There is a fixed rate and no competition in Budapest.
I dare to write that the health financing situation is becoming increasingly muddled. With all three health insurance companies (allegedly) starting to cut their losses, the problem of financing Slovak healthcare has moved up a notch. Of course, it is too early to be scared, but from a systemic point of view, any future financial problems of the health insurance companies would be much more serious than the financial problems of the hospitals.
The number of health professionals is a globally discussed issue. The WHO expects 18 million missing health professionals by 2030, mainly in lower- and middle-income countries. Two out of five active doctors in the United States will be 65 years of age or older in the next decade.
Throughout the last year and a half, the COVID-19 pandemic has revealed weaknesses in healthcare, education, digitalization, and data collection, just to name a few. The shortages of essential goods experienced by many countries during the pandemic has inspired some to turn inwards.
Afghanistan is in immense economic and social insecurity and on top of that, millions of people are wondering what to expect in the upcoming period, after the violent Taliban takeover. Are the Taliban concerned with how children’s lives change?
While digitalization has been advancing in many aspects of human life, the COVID-19 pandemic has accelerated changes in workplaces, trade, doing business, healthcare, education, public administration, and many other spheres.
The European Commission has launched an initiative on the evaluation and revision of the general pharmaceutical legislation with an overall aim to ensure a future-proof and crisis-resistant regulatory system.